ATE207348T1 - Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix - Google Patents

Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix

Info

Publication number
ATE207348T1
ATE207348T1 AT96942011T AT96942011T ATE207348T1 AT E207348 T1 ATE207348 T1 AT E207348T1 AT 96942011 T AT96942011 T AT 96942011T AT 96942011 T AT96942011 T AT 96942011T AT E207348 T1 ATE207348 T1 AT E207348T1
Authority
AT
Austria
Prior art keywords
improved method
matrix
dispersion
crystal formation
liquid substance
Prior art date
Application number
AT96942011T
Other languages
English (en)
Inventor
John W Dohner
Scott A Bura
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE207348T1 publication Critical patent/ATE207348T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal (AREA)
AT96942011T 1995-12-01 1996-11-15 Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix ATE207348T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56622895A 1995-12-01 1995-12-01
PCT/US1996/018397 WO1997020550A2 (en) 1995-12-01 1996-11-15 Improved method for preventing crystal formation in a dispersion of a liquid in a matrix

Publications (1)

Publication Number Publication Date
ATE207348T1 true ATE207348T1 (de) 2001-11-15

Family

ID=24262030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942011T ATE207348T1 (de) 1995-12-01 1996-11-15 Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix

Country Status (8)

Country Link
US (3) US6569448B1 (de)
EP (1) EP0863751B1 (de)
JP (1) JP4166276B2 (de)
AT (1) ATE207348T1 (de)
AU (1) AU1120097A (de)
DE (1) DE69616370T2 (de)
ES (1) ES2162124T3 (de)
WO (1) WO1997020550A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662928A (en) * 1995-04-21 1997-09-02 Ciba-Geigy Corporation Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
DE69716737T2 (de) * 1996-07-03 2003-03-20 Alza Corp., Palo Alto Vorrichtungen zur arzneistoffabgabe und herstellungsverfahren
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
DE19738643C2 (de) 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
JP4215188B2 (ja) 1997-12-22 2009-01-28 インターシア セラピューティクス，インコーポレイティド 薬剤供給を調節するデバイスのための速度調節膜
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CN102099020B (zh) * 2008-05-30 2013-09-18 迈兰股份有限公司 稳定的透皮药物递送系统
AU2009302853B2 (en) * 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
JP5766475B2 (ja) 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
DE102011090178A1 (de) * 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
JP5270035B1 (ja) 2012-12-06 2013-08-21 久光製薬株式会社 貼付剤及びその製造方法
JP5307931B1 (ja) 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
DE102018120505A1 (de) 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4436741A (en) 1975-12-08 1984-03-13 Alza Corporation Method for administering scopolamine transdermally
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4308621A (en) * 1978-09-01 1981-12-29 Mendelson Jerry M Radio interference bucker apparatus
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
DE4223360C1 (de) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5662928A (en) * 1995-04-21 1997-09-02 Ciba-Geigy Corporation Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system

Also Published As

Publication number Publication date
US6569448B1 (en) 2003-05-27
ES2162124T3 (es) 2001-12-16
EP0863751A2 (de) 1998-09-16
WO1997020550A3 (en) 1997-08-14
US20040047893A1 (en) 2004-03-11
JP2000505061A (ja) 2000-04-25
US20010038850A1 (en) 2001-11-08
JP4166276B2 (ja) 2008-10-15
WO1997020550A2 (en) 1997-06-12
AU1120097A (en) 1997-06-27
DE69616370D1 (de) 2001-11-29
DE69616370T2 (de) 2002-07-11
EP0863751B1 (de) 2001-10-24
US7169409B2 (en) 2007-01-30

Similar Documents

Publication Publication Date Title
ATE207348T1 (de) Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix
AU2155597A (en) A Transdermal therapeutic system with small application thickness and high flexibility, as well as processes for its production
TWI263847B (en) Optical film, method for producing the same, and image display device using the same
DE59608749D1 (de) Verfahren zur herstellung transdermaler therapeutischer pflaster (tts)
DK0639990T3 (da) Fremgangsmåde til fremstilling af et hydrofilt overtræk på en overflade og en medicinsk indretning fremstillet ved fremgangsmåden
ATE204162T1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
WO2006063021A3 (en) Coatngs with crystallized active agents (s)
UA75917C2 (en) METHOD TO TREAT SEED WITH AN AGRICULTURALLYûACTIVE SUBSTANCE, TREATED SEED AND A METHOD TO PROTECT SEED
ATE200028T1 (de) Transdermale abgabe vorrichtung
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
GB2345246B (en) Transdermal drug delivery system
EP1227174A3 (de) Verfahren zum Ätzen von Aluminium und Vorrichtung dazu
DE50212267D1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
ATE173645T1 (de) Verfahren und vorrichtung zur herstellung eines transdermalen therapiesystems
DK1311630T3 (da) Todelt vandig metalbeskyttelsesbehandling
ATE201997T1 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
AU7290296A (en) Methods for decomposing quinolones and naphthyridones
ATE232726T1 (de) Pharmazeutische formulierung zur prophylaxe bzw. vorbehandlung einer vergiftung durch phosphororganische cholinesterasehemmer
ATE451108T1 (de) Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung
BR9506279A (pt) Composição para uso em um sistema de liberação de droga transdérmica sistema de liberação transdérmica processo de administração de estrogênio através da pele e uso de um sistema de liberação transdérmica
DE69222430D1 (de) Bistabile magnetooptische einkristallfilme sowie verfahren zu deren herstellung durch kontrollierte einführung von fehlstellen
US20110250147A1 (en) Method and System for Reducing Skin Friction
ATE514736T1 (de) Verfahren zur behandlung von polyazolfolien
RU2000123123A (ru) Способ лечения длительно незаживающих ран

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties